Skip to main content

Prototype Prescribing Outlier Dashboard for Riverside Surgery

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all Practices. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given Practice is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all Practice's chemical:subparagraph ratios is provided, with this Practice's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where Riverside Surgery is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Dithranol 2 Preparations for psoriasis 9 0.22 0.00 0.01 24.66
Indoramin 32 Drugs for urinary retention 204 0.16 0.00 0.01 18.01
Leflunomide 64 Rheumatic disease suppressant drugs 110 0.58 0.05 0.05 10.62
Wool alcohols 7 Emollients 82 0.09 0.00 0.01 10.61
Estradiol valerate 43 Oestrogens and Hormone Replacement Therapy 107 0.40 0.03 0.04 10.57
Hamamalis 2 Other anti-inflammatory preparations 22 0.09 0.00 0.01 9.26
Amisulpride 122 Antipsychotic drugs 438 0.28 0.03 0.04 6.75
Pneumococcal 1 Vaccines and antisera 1 1.00 0.05 0.14 6.69
Clindamycin phosphate 10 Topical preparations for acne 26 0.38 0.06 0.06 5.72
Metoprolol tartrate 84 Beta-adrenoceptor blocking drugs 1,439 0.06 0.01 0.01 5.69

Prescribing where Riverside Surgery is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Aciclovir 8 Herpes simplex and varicella-zoster 13 0.62 0.95 0.07 -5.08
Combined ethinylestradiol 30mcg 36 Combined hormonal contraceptives 74 0.49 0.81 0.07 -4.49
Influenza 0 Vaccines and antisera 1 0.00 0.88 0.28 -3.13
    Zinc oxide 0 Soothing haemorrhoidal preparations 1 0.00 0.77 0.26 -3.01
      Tamsulosin hydrochloride 152 Drugs for urinary retention 204 0.75 0.92 0.06 -2.94
      Atorvastatin 1,395 Lipid-regulating drugs 3,069 0.45 0.67 0.08 -2.65
      Calcipotriol 6 Preparations for psoriasis 9 0.67 0.87 0.08 -2.55
      Benzoyl peroxide and clindamycin phosphate 1 Topical preparations for acne 26 0.04 0.38 0.13 -2.50
      Hydroxychloroquine sulfate 0 Rheumatic disease suppressant drugs 110 0.00 0.37 0.16 -2.37
        Sulfasalazine 0 Aminosalicylates 31 0.00 0.33 0.14 -2.33